American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition. (DMS-IV)Washington (DC): American Psychiatric Association, 1994.
2.
AwaadY. Tics in Tourette syndrome: New treatment options. J Child Neurol, 14:316–319. 1999.
3.
McDougleCJ, EppersonCN, PeltonGH, WasylinkS, PriceL. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Arch Gen Psychiatry, 57:794–801. 2000.
4.
McDougleCJ, FleischmannR, EppersonC, WasylinkS, LeckmanJF, PriceLH. Risperidone addition in fluvoxamine-refractory obsessive compulsive disorder: Three cases. J Clin Psychiatry, 56:526–528. 1995.
5.
McDougleCJ, GoodmanWK, PriceLH, DelgadoPL, KrystalJH, CharneyDS, HeningerGR. Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder. Am J Psychiatry, 147:652–654. 1990.
6.
MiguelEC, BaerL, CoffeyBJ, RauchSL, SavageCR, O'SullivanRL, PhillipsK, MorettiC, LeckmanJF, JenikeMA. Phenomenological differences appearing with repetitive behaviours in obsessive-compulsive disorder and Gilles de la Tourette's syndrome. Brit J Psychiatry, 170:140–145. 1997.
7.
PalumboD, KurlanR. Complex obsessive compulsive and impulsive symptoms in Tourette's Syndrome. Neuropsych Dis Treat, 3:687–693. 2007.
8.
PalumboD, MaughanA, KurlanR. Hypothesis III: Tourette's syndrome is only one of several causes of developmental basal ganglia syndrome. Arch Neurology, 54:475–483. 1997.